case / 18 Apr 2024

Setterwalls advises BrainCool in connection with a rights issue

Responsive image
Setterwalls advises BrainCool AB (publ), listed on Nasdaq First North Growth Market, in connection with a rights issue of shares.
BrainCool is an innovative medical technology company that develops, markets and sells leading medical cooling systems for indications and areas with significant medical added value in healthcare. BrainCool is headquartered in Lund, Sweden. Through the rights issue, BrainCool may receive issue proceeds of approximately SEK 85.8 million before issue costs.

Contact:

Ola Grahn, Gustav Johansson, Elsa Economou Olsson, Erik Olshov, Jonathan Lindström

Practice areas:

Equity Capital Markets, Corporate law, Life Sciences

Do you want to get in touch with us?

Please fill out the form and we will contact you as soon as possible.

  • This field is for validation purposes and should be left unchanged.

Related news

European Parliament adopts new directive on Corporate Sustainability Due Diligence – Three takeaways

article / 30 Apr 2024

European Parliament adopts new directive on Corporate Sustainability Due Diligence – Three takeaways

Read more
Setterwalls has advised Freemelt in connection with a rights issue

case / 25 Apr 2024

Setterwalls has advised Freemelt in connection with a rights issue

Read more
Setterwalls has advised Infrea in connection with a rights issue

case / 23 Apr 2024

Setterwalls has advised Infrea in connection with a rights issue

Read more
Load more